Forte Biosciences (FBRX) Interest Expenses (2016 - 2026)

Forte Biosciences (FBRX) has 11 years of Interest Expenses data on file, last reported at $43.7 million in Q1 2026.

• On a quarterly basis, Interest Expenses rose 5211.44% year-over-year to $43.7 million in Q1 2026; TTM through Mar 2026 was $43.7 million, a 5211.44% increase from a year earlier, with the FY2025 full-year figure at $47.1 million, up 92.12% from the prior year.
• Interest Expenses for Q1 2026 stood at $43.7 million, up from $43000.0 in the prior quarter.
• Over the last five years, Interest Expenses for FBRX reached as high as $43.7 million in Q1 2026 and fell as low as $5000.0 in Q3 2023.
• Historically, Interest Expenses has averaged $4.5 million across 5 years, with a median of $81000.0 in 2024.
• Across the five-year window, Interest Expenses slumped 99.32% in 2022 and jumped 62082.14% in 2025, its largest moves.
• Year by year, Interest Expenses stood at $65000.0 in 2022, then tumbled by 53.85% to $30000.0 in 2023, then jumped by 170.0% to $81000.0 in 2024, then tumbled by 46.91% to $43000.0 in 2025, then surged by 101434.88% to $43.7 million in 2026.
• Per Business Quant data, the three most recent Interest Expenses figures were $43.7 million in Q1 2026, $43000.0 in Q4 2025, and $17.4 million in Q3 2025.